Literature DB >> 32979387

Prolonged Tracheal Intubation and the Association Between Patent Ductus Arteriosus and Bronchopulmonary Dysplasia: A Secondary Analysis of the PDA-TOLERATE trial.

Ronald I Clyman1, Joseph Kaempf2, Melissa Liebowitz3, Omer Erdeve4, Ali Bulbul5, Stellan Håkansson6, Johanna Lindqvist6, Aijaz Farooqi6, Anup Katheria7, Jason Sauberan7, Jaideep Singh8, Kelly Nelson8, Andrea Wickremasinghe9, Lawrence Dong9, Denise C Hassinger10, Susan W Aucott11, Madoka Hayashi11, Anne Marie Heuchan12, William A Carey13, Matthew Derrick14, Erika Fernandez15, Meera Sankar16, Tina Leone17, Jorge Perez18, Arturo Serize18.   

Abstract

In the PDA-TOLERATE trial, persistent (even for several weeks) moderate to large patent ductus arteriosus (PDA) was not associated with an increased risk of BPD when the infant required <10 days of intubation. However, in infants requiring intubation for ≥10 days, prolonged PDA exposure (≥11 days) was associated with an increased risk of moderate/severe BPD.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bronchopulmonary dysplasia; patent ductus arteriosus; premature birth

Mesh：

Year:  2020        PMID： 32979387      PMCID： PMC7855529          DOI： 10.1016/j.jpeds.2020.09.047

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  26 in total

1.  Severity of the ductal shunt: a comparison of different markers.

Authors:  M El Hajjar; G Vaksmann; T Rakza; G Kongolo; L Storme
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-09       Impact factor: 5.747

2.  Duration of significant patent ductus arteriosus and bronchopulmonary dysplasia in extremely preterm infants.

Authors:  Hussnain Mirza; Jorge Garcia; Genevieve McKinley; Laura Hubbard; Wendla Sensing; Jordan Schneider; William Oh; Rajan Wadhawan
Journal:  J Perinatol       Date:  2019-09-25       Impact factor: 2.521

Review 3.  Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis?

Authors:  W E Benitz
Journal:  J Perinatol       Date:  2010-02-25       Impact factor: 2.521

4.  Relationship between Duration of Infant Exposure to a Moderate-to-Large Patent Ductus Arteriosus Shunt and the Risk of Developing Bronchopulmonary Dysplasia or Death Before 36 Weeks.

Authors:  Ronald I Clyman; Nancy K Hills; Melissa Liebowitz; Sandy Johng
Journal:  Am J Perinatol       Date:  2019-10-10       Impact factor: 1.862

Review 5.  Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.

Authors:  Arne Ohlsson; Rajneesh Walia; Sachin S Shah
Journal:  Cochrane Database Syst Rev       Date:  2015-02-18

6.  Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants.

Authors:  Matthew M Laughon; John C Langer; Carl L Bose; P Brian Smith; Namasivayam Ambalavanan; Kathleen A Kennedy; Barbara J Stoll; Susie Buchter; Abbot R Laptook; Richard A Ehrenkranz; C Michael Cotten; Deanne E Wilson-Costello; Seetha Shankaran; Krisa P Van Meurs; Alexis S Davis; Marie G Gantz; Neil N Finer; Bradley A Yoder; Roger G Faix; Waldemar A Carlo; Kurt R Schibler; Nancy S Newman; Wade Rich; Abhik Das; Rosemary D Higgins; Michele C Walsh
Journal:  Am J Respir Crit Care Med       Date:  2011-03-04       Impact factor: 21.405

7.  Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging.

Authors:  M J Bell; J L Ternberg; R D Feigin; J P Keating; R Marshall; L Barton; T Brotherton
Journal:  Ann Surg       Date:  1978-01       Impact factor: 12.969

8.  PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age.

Authors:  Ronald I Clyman; Melissa Liebowitz; Joseph Kaempf; Omer Erdeve; Ali Bulbul; Stellan Håkansson; Johanna Lindqvist; Aijaz Farooqi; Anup Katheria; Jason Sauberan; Jaideep Singh; Kelly Nelson; Andrea Wickremasinghe; Lawrence Dong; Denise C Hassinger; Susan W Aucott; Madoka Hayashi; Anne Marie Heuchan; William A Carey; Matthew Derrick; Erika Fernandez; Meera Sankar; Tina Leone; Jorge Perez; Arturo Serize
Journal:  J Pediatr       Date:  2018-10-16       Impact factor: 4.406

9.  The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach.

Authors:  Erik A Jensen; Kevin Dysart; Marie G Gantz; Scott McDonald; Nicolas A Bamat; Martin Keszler; Haresh Kirpalani; Matthew M Laughon; Brenda B Poindexter; Andrea F Duncan; Bradley A Yoder; Eric C Eichenwald; Sara B DeMauro
Journal:  Am J Respir Crit Care Med       Date:  2019-09-15       Impact factor: 21.405

10.  The effect of prolonged tracheal intubation on the association between patent ductus arteriosus and bronchopulmonary dysplasia (grades 2 and 3).

Authors:  Ronald I Clyman; Nancy K Hills
Journal:  J Perinatol       Date:  2020-07-15       Impact factor: 2.521
View more
  8 in total

1.  Continuing interventions in a quality improvement bundle to reduce bronchopulmonary dysplasia.

Authors:  Yan-Ping Xu; Li-Ping Shi; Li-Zhong Du
Journal:  World J Pediatr       Date:  2022-02-18       Impact factor: 2.764

2.  Risk factors and bronchopulmonary dysplasia severity: data from the Spanish Bronchopulmonary Dysplasia Research Network.

Authors:  Cristina Ramos-Navarro; Elena Maderuelo-Rodríguez; Ana Concheiro-Guisán; Santiago Pérez-Tarazona; Santiago Rueda-Esteban; Ana Sánchez-Torres; Manuel Sánchez-Solís; Ester Sanz-López; Manuel Sánchez-Luna
Journal:  Eur J Pediatr       Date:  2021-10-01       Impact factor: 3.183

3.  The Ideal Timing of Bedside Surgical Ligation of Patent Ductus Arteriosus in Premature Babies Less Than 30 Gestational Weeks.

Authors:  Adil Umut Zübarioğlu; Özgür Yıldırım; Cenap Zeybek; İsmail Balaban; Bahruz Aliyev; Volkan Yazıcıoğlu; Ercan Tutak; Mesut Dursun; Ebru Türkoğlu Ünal; Nursu Kara
Journal:  Turk Arch Pediatr       Date:  2021-07

4.  A Matched Case Control Study of Surgically and Non-surgically Treated Patent Ductus Arteriosus in Extremely Pre-term Infants.

Authors:  Karl Wilhelm Olsson; Sawin Youssef; Mattias Kjellberg; Renske Raaijmakers; Richard Sindelar
Journal:  Front Pediatr       Date:  2021-03-18       Impact factor: 3.418

5.  The Change of Cytokines and Gut Microbiome in Preterm Infants for Bronchopulmonary Dysplasia.

Authors:  Zhenjie Zhang; Jingjing Jiang; Zhenghong Li; Weilin Wan
Journal:  Front Microbiol       Date:  2022-03-21       Impact factor: 5.640

6.  Impact of patent ductus arteriosus shunt size and duration on risk of death or severe respiratory morbidity in preterm infants born in China.

Authors:  Yingping Deng; Haiyan Zhang; Zhuoyu Zhao; Juan Du; Ruimiao Bai; Patrick J McNamara
Journal:  Eur J Pediatr       Date:  2022-07-15       Impact factor: 3.860

Review 7.  Sex Differences in Patent Ductus Arteriosus Incidence and Response to Pharmacological Treatment in Preterm Infants: A Systematic Review, Meta-Analysis and Meta-Regression.

Authors:  Moreyba Borges-Lujan; Gema E Gonzalez-Luis; Tom Roosen; Maurice J Huizing; Eduardo Villamor
Journal:  J Pers Med       Date:  2022-07-14

8.  An Update on Patent Ductus Arteriosus and What is Coming Next.

Authors:  Ömer Erdeve; Emel Okulu; Yogen Singh; Richard Sindelar; Mehmet Yekta Oncel; Gianluca Terrin; Giovanni Boscarino; Ali Bülbül; Hannes Sallmon; Begüm Atasay; Fahri Ovalı; Ronald I Clyman
Journal:  Turk Arch Pediatr       Date:  2022-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.